Regulations.gov document
Appendix 1 FDA Guidance for Industry Immunogenicity Related Considerations for the…
Supporting & Related Material · FDA-2014-D-0310 · posted Jun 16, 2014
Key facts
| Document ID | FDA-2014-D-0310-0004 |
|---|---|
| Title | Appendix 1 FDA Guidance for Industry Immunogenicity Related Considerations for the Approval of Low Molecular Weight Heparin for NDAs and ANDAs Comment from Amphastar Pharmaceuticals Inc |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2014-D-0310 |
| Posted | Jun 16, 2014 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: